THE ADENOID CYSTIC CARCINOMA RESEARCH FOUNDATION (EIN 206745475) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

JEFFREY A KAUFMAN

Phone

7812489699

Tax Period

2023-01-01 to 2023-12-31

THE ADENOID CYSTIC CARCINOMA RESEARCH FOUNDATION, founded in 2005, is a community nonprofit in the Medical Research sector that reported $1.9M in total revenue in fiscal year 2023. Revenue surged 37% from the prior year, signaling strong growth momentum.

Mission

SUPPORTING RESEARCH INTO THE TREATMENT AND CURE OF ADENOID CYSTIC CARCINOMA.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $748,287

Program Service Revenue $1,054,422

Investment Income $90,836

Other Revenue $0

TOTAL REVENUE $1,893,545

Expense Breakdown

Grants Paid $225,883

Salaries & Benefits $391,271

Fundraising Expenses $30,208

Program Expenses $1,724,978

Other Expenses $1,255,566

TOTAL EXPENSES $1,872,720

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,893,545	$1,386,655	+0.4%
Expenses	$1,872,720	$1,618,196	+0.2%
Net Income	$20,825	$-231,541	-1.1%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$150,000

Total Directors

$150,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JEFFREY A KAUFMAN	EXECUTIVE DIRECTOR/BOARD C	50.00	Officer Director	$150,000	$0	$150,000
THOMAS DILENGE	BOARD VICE CHAIR	5.00	Officer Director	$0	$0	$0
RALPH MOLLIS	TREASURER	5.00	Officer Director	$0	$0	$0
MARNIE A KAUFMAN	DIRECTOR & CFO	35.00	Director	$0	$0	$0
ELIZABETH WEHLAGE	DIRECTOR	5.00	Director	$0	$0	$0
LISA BHAKRI	DIRECTOR	5.00	Director	$0	$0	$0
DAVID MORSE	DIRECTOR	5.00	Director	$0	$0	$0
BOZHO TODORICH	DIRECTOR	5.00	Director	$0	$0	$0
EMMA KINLOCH	DIRECTOR	5.00	Director	$0	$0	$0
NICOLE SPARDY BURR	DIRECTOR OF RESEARCH	40.00	Highest	$135,000	$0	$135,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,893,545	$1,872,720	$2,690,770	$20,825
2022	$1,386,655	$1,618,196	$2,659,707	$-231,541
2021	$2,427,133	$2,071,023	$3,133,519	$356,110
2020	$1,208,448	$1,420,993	$2,608,038	$-212,545
2019	$2,103,655	$1,225,852	$2,646,923	$877,803
2018	$2,043,147	$1,294,454	$1,935,482	$748,693

THE ADENOID CYSTIC CARCINOMA RESEARCH FOUNDATION